The researchers will be testing the effects of rosiglitazone, a drug currently on the market to treat diabetes, on the success rate of IF in women with endometriosis.

• 研究人员将研究罗格列酮对子宫内膜异位妇女IF成功率的影响，罗格列酮是目前市场上用于治疗糖尿病的药物。